Brand Name: Lantus Active Ingredient: insulin glargine (rDNA origin) injection Indication: Treatment of adults and children with type 1 diabetes mellitus, and adults with type 2 diabetes mellitus who require long-acting insulin for control of hyperglycemia Company Name: Aventis Pharmaceuticals Availability: FDA approved Lantus for marketing on April 24, 2000; may be available in late 2000 Lantus: Introduction For many diabetics, each day is structured around the administration of multiple insulin injections to control their blood sugar levels. Now a new form of insulin will soon be available that may make life easier for many diabetics who require these …
[ Continue Reading... ]Category: Antidiabetics
Brand Name: Effexor XR Active Ingredient: venlafaxine hydrochloride Indication: Treatment of diabetic neuropathy (investigational) Company Name: Wyeth-Ayerst Availability: Approved by the FDA in 1993 for the treatment of depression and anxiety Effexor: Introduction The drug Effexor (venlafaxine hydrochloride) was approved by the FDA in 1993 for the treatment of depression and anxiety. An extended-release once-daily dosing preparation, Effexor XR, received marketing clearance in 1997. Now Effexor XR is showing promise for ameliorating the symptoms of another disorder: diabetic neuropathy. The results of the study were reported at the 60th annual meeting of the American Diabetes Association in June 2000. In doses ranging …
[ Continue Reading... ]